Hydroxychloroquine (International)
In the US, Hydroxychloroquine (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Lichen Planopilaris, Lupus, Lyme Disease - Arthritis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome and Undifferentiated Connective Tissue Disease.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
P01BA02
CAS registry number (Chemical Abstracts Service)
0000118-42-3
Chemical Formula
C18-H26-Cl-N3-O
Molecular Weight
336
Therapeutic Categories
Antiprotozoal agent: Antimalarial
Disease-modifying antirheumatic drug, DMARD
Chemical Name
Etanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]etylamino]-
Foreign Names
- Hydroxychloroquinum (Latin)
- Hydroxychloroquin (German)
- Hydroxychloroquine (French)
- Hidroxicloroquina (Spanish)
Generic Names
- Hydroxychloroquine (OS: BAN)
- Idroxiclorochina (OS: DCIT)
- Oxychloroquine (IS)
- Win 1258-2 (IS)
- Hydroxychloroquine (PH: Ph. Eur. 9.3)
- Hydroxychloroquine Sulfate (OS: BANM, JAN)
- Hydroxychloroquine Sulfate (PH: BP 2018, Ph. Eur. 9.3, USP 41)
- Hydroxychloroquini sulfas (PH: Ph. Eur. 9.3)
Brand Names
- Axokine
Rontag, Argentina - Dimard
Metlen, Ecuador - Hidroxiplus
Perulab, Peru - Hydrocad
Cadila, India - Hydroquin
Sun Pharma, Thailand - Ilinol
Pharma Investi de Chile, Chile - Mcqs
Molekule, India - Narbon
Buxton, Argentina - Plaquenil
Concordia Pharmaceuticals, United States; Sanofi Aventis, Tunisia - Plaquinol
Sanofi-Aventis, Peru - Polireumin
Perulab, Peru - Quinilen
Royal Pharma, Chile - Quinoric
Bristol Laboratories, Cyprus; Sanolabor, Slovenia - Reumaquin
AC Farma, Peru - Supretic
Eticos, Paraguay - Zy-Q
Zydus, India - APO-Hydroxychloroquine
Apotex, Australia - Apo-Hydroxychloroquine Sulfate
Apotex, Hong Kong - Apo-Hydroxyquine
Apotex, Canada - Be-easy
Shinlon, Taiwan - Chloguin
Weidar, Taiwan - Dimard
Siegfried, Colombia - Dolquine
Rubio, Spain - Evoquin
Ivax, Argentina; Teva, Uruguay - Fen Le
ZhongXi Pharmaceutical, China - Geniquin
Genovate, Taiwan - Haloxin
Hanlim, South Korea - HCQS
IPCA, Thailand - Hequinel
Arrow Pharmaceuticals, Australia - Hidroxicloroquina Sulfato Pharma Arte
Pharma Arte, Paraguay - Hydroquine
Minapharm, Egypt; Taiwan Biotech, Taiwan - Hydroxychloroquine
Apotex, Russian Federation - Hydroxychloroquine AN
Amneal Pharma, Australia - Hydroxychloroquine GH
Generic Health, Australia - Hydroxychloroquine RBX
Ranbaxy, Australia - Hydroxychloroquine sulfate
Zentiva, United Kingdom - Hydroxychloroquine Sulfate
Hikma, United States; Ipca, United States; Mylan, United States; Sandoz, United States; Teva, United States; Watson Pharmaceutical, United States; Zydus Pharma, United States - Hydroxychloroquine Sulfate Lenis
LENIS, Slovenia - Hydroxychloroquine Sulphate P & D
P & D, Malta - Hydroxychloroquine Zentiva 200mg
Helvepharm, Switzerland - Hydroxychloroquinesulfaat CF
Centrafarm, Netherlands - Metirel
Pfizer, Uruguay; Rontag, Argentina - Mylan-Hydroxychloroquine
Mylan Pharmaceuticals, Canada - Oxiklorin
Kyung Poong, South Korea; Orion Pharma, Finland - Plaquenil
Abbott Laboratories S.A., China; Dr. Fisher Farma, Netherlands; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; First Pharma, Estonia; Lex ano, Lithuania; Sanofi, Denmark; Sanofi, Ireland; Sanofi, Japan; Sanofi, Sweden; Sanofi Aventis, China; Sanofi Belgium, Belgium; Sanofi Israel, Israel; Sanofi Malta, Malta; Sanofi Romania, Romania; Sanofi Winthrop, Kuwait; Sanofi-Aventis, Argentina; Sanofi-Aventis, Australia; Sanofi-Aventis, Canada; Sanofi-Aventis, Cyprus; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Estonia; Sanofi-Aventis, France; Sanofi-Aventis, Georgia; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Philippines; Sanofi-Aventis, Slovakia; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis Netherlands, Netherlands; Sanofi-Aventis SA, Greece; synth, Egypt - Plaquenil 200mg
Sanofi Belgium, Luxembourg; Sanofi-Aventis, Switzerland - Plaquenil-Hydroxychloroquine sulfate
Zentiva, United Kingdom - Plaquinol
Alfa Wassermann, Portugal; Sanofi Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Paraguay; Sanofi-Aventis, Venezuela; Sanofi-Aventis Farmaceutica, Brazil - Polirreumin
TRB Pharma, Argentina - Pro-Hydroxyquine
Pro Doc, Canada - Quensyl 200mg
Sanofi-Aventis Deutschland, Germany - Quinoric
Bristol Laboratories, United Kingdom; Central Procurement & Supplies Unit, Malta - Reumazine
Instituto Sanitas, Chile - Reuquinol
Apsen, Brazil
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.